DeepCell

Company profile

About DeepCell

Deepcell is a life sciences technology company that combines artificial intelligence, high-resolution imaging, and microfluidics to decode cell identity and function through morphology. The company's flagship REM-I platform represents a breakthrough in single-cell analysis, enabling label-free imaging, AI-powered characterization, and gentle enrichment of viable cells based on their physical characteristics. At the heart of the platform is Deepcell's Human Foundation Model (HFM), a self-supervised AI trained on billions of single-cell images that extracts a 115-dimensional embedding from every brightfield cell image in real-time. This foundation model captures both human-interpretable morphological features and deeper patterns invisible to the eye, requiring no bespoke training for new applications or sample types. The platform combines high-speed, high-resolution brightfield imaging with gentle microfluidics for 6-way sorting, ensuring cells remain minimally perturbed and viable for downstream analysis. Deepcell pioneered the field of "morpholomics" — the high-dimensional, label-free study of cell morphology as a quantifiable data layer on par with genomics, transcriptomics, and proteomics. The company serves researchers across oncology, drug discovery, cell and gene therapy, regenerative medicine, transplant monitoring, and other areas of cell science. The integrated AXON data suite provides cloud and on-premises solutions for data visualization, analysis, and storage, enabling researchers to gain actionable insights within minutes without bioinformatics support. Founded from research at Stanford University, Deepcell continues to push the boundaries of cell science by revealing insights that no molecular marker or label could predict.

Company description · DeepCell official website